Selection of outcome measurement instruments for a core outcome set for trials aimed at improving appropriate polypharmacy in older people in primary care: a Delphi consensus study
International Journal of Clinical Pharmacy · 2024
DOI: 10.1007/s11096-024-01780-4 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift International Journal of Clinical Pharmacy, 2024. Verfasst von Mubarak N Alqahtani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK. Hauptthemen laut MEDLINE: Delphi Technique, Polypharmacy, Primary Health Care, Outcome Assessment, Health Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saudi Arabia Cultural Bureau in London.
Abstract (Originalsprache)
Background
Despite developing a polypharmacy core outcome set (COS) in primary care, it is not clear how these outcomes should be measured.
Aim
To select outcome measurement instruments (OMIs) for a COS targeting appropriate polypharmacy in older patients in primary care.
Method
Following the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) guideline, OMIs were identified from a Cochrane review focusing on appropriate polypharmacy. The quality of OMIs was assessed using a published checklist. Subsequently, two rounds of Delphi questionnaires were conducted via the SoGoSurvey ® platform, engaging stakeholders (researchers, clinicians and journal editors specialising in geriatric primary care) to achieve consensus on OMIs using a scale encompassing “agree”, “disagree”, or “unsure”. Consensus was achieved if 70% or more participants chose “agree” and 15% or fewer chose “disagree.” Results The quality of 20 OMIs identified from the Cochrane review was evaluated. Seven OMIs were selected based on meeting the COSMIN guideline’s minimum requirements. Out of 188 potential participants, 57 (30.3%) consented to participate. Rounds 1 and 2 of Delphi exercises were completed by 50 respondents, achieving agreement on three OMIs: ‘number of serious adverse drug reactions (ADRs)’ (98%), ‘number of deaths’ (76%), and ‘number of patients who fell’ (70%) for measuring ‘serious ADRs,’ ‘mortality,’ and ‘falls,’ respectively. No agreement was reached for ‘medication appropriateness,’ ‘medication side-effects,’ ‘quality of life,’ and ‘medication regimen complexity.’ Conclusion OMIs were selected for a limited number of outcomes in the polypharmacy COS. Future research should identify suitable OMIs for the remaining four outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
- Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK. c.hughes@qub.ac.uk.
Förderung
- Saudi Arabia Cultural Bureau in London
Zitieren
APA
Alqahtani, M. N., Barry, H. E., & Hughes, C. M. (2024). Selection of outcome measurement instruments for a core outcome set for trials aimed at improving appropriate polypharmacy in older people in primary care: a Delphi consensus study. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-024-01780-4
Vancouver
Alqahtani MN, Barry HE, Hughes CM. Selection of outcome measurement instruments for a core outcome set for trials aimed at improving appropriate polypharmacy in older people in primary care: a Delphi consensus study. International Journal of Clinical Pharmacy. 2024. doi:10.1007/s11096-024-01780-4
BibTeX
@article{Alqahtani2024,
author = {Alqahtani, Mubarak N and Barry, Heather E and Hughes, Carmel M},
title = {Selection of outcome measurement instruments for a core outcome set for trials aimed at improving appropriate polypharmacy in older people in primary care: a Delphi consensus study},
journal = {International Journal of Clinical Pharmacy},
year = {2024},
doi = {10.1007/s11096-024-01780-4}
}
EUVIMED